GSK loses suit against CNIPA over dose inhaler patent
China’s Beijing Intellectual Property Court on September 9 ruled in favor of CNIPA in its lawsuit against British drugmaker GlaxoSmithKline, impleading Chinese drugmaker Chia Tai Tianqing Pharmaceutical Group Co., Ltd. as the third-party defendant.

